Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 167

1.

Insights from Computer Modeling: Analysis of Physical Characteristics of Glioblastoma in Patients Treated with Tumor-Treating Fields.

Lok E, San P, Wong ET.

In: Makarov S, Horner M, Noetscher G, editors. Brain and Human Body Modeling: Computational Human Modeling at EMBC 2018 [Internet]. Cham (CH): Springer; 2019. Chapter 8.
2019 Aug 28.

2.

Investigating the Connection Between Tumor-Treating Fields Distribution in the Brain and Glioblastoma Patient Outcomes. A Simulation-Based Study Utilizing a Novel Model Creation Technique.

Urman N, Levy S, Frenkel A, Manzur D, Hershkovich HS, Naveh A, Yesharim O, Wenger C, Lavy-Shahaf G, Kirson E, Bomzon Z.

In: Makarov S, Horner M, Noetscher G, editors. Brain and Human Body Modeling: Computational Human Modeling at EMBC 2018 [Internet]. Cham (CH): Springer; 2019. Chapter 7.
2019 Aug 28.

3.

Estimation of TTFields Intensity and Anisotropy with Singular Value Decomposition: A New and Comprehensive Method for Dosimetry of TTFields.

Korshoej AR.

In: Makarov S, Horner M, Noetscher G, editors. Brain and Human Body Modeling: Computational Human Modeling at EMBC 2018 [Internet]. Cham (CH): Springer; 2019. Chapter 10.
2019 Aug 28.

4.

Water-Content Electrical Property Tomography (wEPT) for Mapping Brain Tissue Conductivity in the 200–1000 kHz Range: Results of an Animal Study.

Wenger C, Hershkovich HS, Tempel-Brami C, Giladi M, Bomzon Z.

In: Makarov S, Horner M, Noetscher G, editors. Brain and Human Body Modeling: Computational Human Modeling at EMBC 2018 [Internet]. Cham (CH): Springer; 2019. Chapter 20.
2019 Aug 28.

5.

Advanced Multiparametric Imaging for Response Assessment to Tumor-Treating Fields in Patients with Glioblastoma.

Mohan S, Wang S, Chawla S.

In: Makarov S, Horner M, Noetscher G, editors. Brain and Human Body Modeling: Computational Human Modeling at EMBC 2018 [Internet]. Cham (CH): Springer; 2019. Chapter 9.
2019 Aug 28.

6.

Tumor treating fields cause replication stress and interfere with DNA replication fork maintenance: Implications for cancer therapy.

Karanam NK, Hao-Ding L, Aroumougame A, Story MD.

Transl Res. 2019 Oct 21. pii: S1931-5244(19)30214-2. doi: 10.1016/j.trsl.2019.10.003. [Epub ahead of print]

PMID:
31707040
7.

Patient Reported Outcome (PRO) Among High-Grade Glioma Patients Receiving TTFields Treatment: A Two Center Observational Study.

Onken J, Goerling U, Heinrich M, Pleissner S, Krex D, Vajkoczy P, Misch M.

Front Neurol. 2019 Oct 1;10:1026. doi: 10.3389/fneur.2019.01026. eCollection 2019.

8.

Temperature control in TTFields therapy of GBM: impact on the duty cycle and tissue temperature.

Gentilal N, Salvador R, Miranda PC.

Phys Med Biol. 2019 Oct 31. doi: 10.1088/1361-6560/ab5323. [Epub ahead of print]

PMID:
31671414
9.

[Tumor treating fields in cancer treatment in Denmark].

Korshøj AR, Lukacova S, Mikic N, Cortnum SOS, Lassen-Ramshad Y, Guldberg TL, Severinsen KE, Thielscher A, Poulsen FR, Sørensen JCH, Oettingen GBV.

Ugeskr Laeger. 2019 Oct 14;181(20A). pii: V07180481. Danish.

PMID:
31610842
10.

Tumor treating fields for glioblastoma: should it or will it ever be adopted?

Thomas AA, Rauschkolb PK.

Curr Opin Neurol. 2019 Dec;32(6):857-863. doi: 10.1097/WCO.0000000000000762.

PMID:
31609738
11.

Evaluation of the Compatibility of Electric Tumor Treating Fields with Key Anti-tumoral T-Cell Functions.

Simchony H, Diamant D, Ram Z, Volovitz I.

Isr Med Assoc J. 2019 Jul;21(7):503.

12.

Cerebral blood volume and apparent diffusion coefficient - Valuable predictors of non-response to bevacizumab treatment in patients with recurrent glioblastoma.

Petrova L, Korfiatis P, Petr O, LaChance DH, Parney I, Buckner JC, Erickson BJ.

J Neurol Sci. 2019 Oct 15;405:116433. doi: 10.1016/j.jns.2019.116433. Epub 2019 Aug 23.

13.

Integration of Tumor-Treating Fields into the Multidisciplinary Management of Patients with Solid Malignancies.

Wang Y, Pandey M, Ballo MT.

Oncologist. 2019 Aug 23. pii: theoncologist.2017-0603. doi: 10.1634/theoncologist.2017-0603. [Epub ahead of print] Review.

PMID:
31444292
14.

Tumor-Treating Fields Induce RAW264.7 Macrophage Activation Via NK-κB/MAPK Signaling Pathways.

Park JI, Song KH, Jung SY, Ahn J, Hwang SG, Kim J, Kim EH, Song JY.

Technol Cancer Res Treat. 2019 Jan 1;18:1533033819868225. doi: 10.1177/1533033819868225.

15.

Tumor-treating fields induce autophagy by blocking the Akt2/miR29b axis in glioblastoma cells.

Kim EH, Jo Y, Sai S, Park MJ, Kim JY, Kim JS, Lee YJ, Cho JM, Kwak SY, Baek JH, Jeong YK, Song JY, Yoon M, Hwang SG.

Oncogene. 2019 Sep;38(39):6630-6646. doi: 10.1038/s41388-019-0882-7. Epub 2019 Aug 2.

PMID:
31375748
16.

The dielectric properties of skin and their influence on the delivery of tumor treating fields to the torso: a study combining in vivo measurements with numerical simulations.

Hershkovich HS, Urman N, Yesharim O, Naveh A, Bomzon Z.

Phys Med Biol. 2019 Sep 19;64(18):185014. doi: 10.1088/1361-6560/ab33c6.

PMID:
31323651
17.

The Role of Checkpoint Inhibitors in Glioblastoma.

Desai K, Hubben A, Ahluwalia M.

Target Oncol. 2019 Aug;14(4):375-394. doi: 10.1007/s11523-019-00655-3. Review.

PMID:
31290002
18.

Quality-adjusted life years in glioma patients: a systematic review on currently available data and the lack of evidence-based utilities.

Butenschoen VM, Kelm A, Meyer B, Krieg SM.

J Neurooncol. 2019 Aug;144(1):1-9. doi: 10.1007/s11060-019-03210-2. Epub 2019 Jun 12. Review.

PMID:
31187319
19.

Cost-effectiveness of tumor-treating fields added to maintenance temozolomide in patients with glioblastoma: an updated evaluation using a partitioned survival model.

Connock M, Auguste P, Dussart C, Guyotat J, Armoiry X.

J Neurooncol. 2019 Jul;143(3):605-611. doi: 10.1007/s11060-019-03197-w. Epub 2019 May 24.

PMID:
31127507
20.

Effectiveness of a Fractionated Therapy Scheme in Tumor Treating Fields Therapy.

Jo Y, Sung J, Jeong H, Hong S, Jeong YK, Kim EH, Yoon M.

Technol Cancer Res Treat. 2019 Jan 1;18:1533033819845008. doi: 10.1177/1533033819845008.

Supplemental Content

Loading ...
Support Center